Cognitive behavioral therapy for perinatal anxiety: A randomized controlled trial

Area of Science:

• Perinatal mental health
• Clinical psychology
• Anxiety disorder treatment

Background:

• Perinatal anxiety affects up to 20% of women, posing risks with psychotropic medications.
• There is a significant need for evidence-based, non-pharmacological interventions for perinatal anxiety.
• This study addresses the demand for safer treatment options during pregnancy and postpartum.

Purpose of the Study:

• To assess the efficacy of a cognitive behavioral group therapy (CBGT) protocol.
• To evaluate CBGT for women experiencing anxiety during the perinatal period.
• To provide an alternative to medication for perinatal anxiety.

Main Methods:

• Ninety-six women with anxiety disorders (with or without depression) were randomized.
• Participants were aged 22-41, pregnant or up to 6 months postpartum.
• The study compared cognitive behavioral group therapy (CBGT) to a waitlist control group.

Main Results:

• CBGT significantly reduced anxiety, worry, perceived stress, and depressive symptoms compared to waitlist.
• Primary anxiety outcomes showed significant improvement (State-Trait Inventory of Cognitive and Somatic Anxiety, Hamilton Anxiety Rating Scale).
• Treatment gains were maintained or improved at 3-month follow-up, irrespective of maternal status or medication use.

Conclusions:

• Cognitive behavioral group therapy (CBGT) is an effective treatment for perinatal anxiety.
• CBGT successfully improves anxiety and associated symptoms in pregnant and postpartum women.
• This non-pharmacological approach offers a viable solution for managing perinatal anxiety disorders.